Sign Up Today and Learn More About Capstan Therapeutics Stock
Invest in or calculate the value of your shares in Capstan Therapeutics or other pre-IPO companies through EquityZen's platform.

Capstan Therapeutics Stock (CAPT)
Capstan Therapeutics is advancing cell engineering to develop therapeutics for a broad range of diseases.
About Capstan Therapeutics Stock
Founded
2021
Headquarters
San Diego, CA, US
Industries
Artificial Intelligence, Software, Data and Analytics
Capstan Therapeutics Press Mentions
Stay in the know about the latest news on Capstan Therapeutics
8 European VC firms to watch in 2026
european-biotechnology • Jun 29, 2026
Can Sanofi buy its way into in vivo CAR-T?
european-biotechnology • Jun 22, 2026
前CDE官员建言:香港CMPR发展空间远超想象
phirda • Jun 19, 2026
818号令实施,体内CAR-T上桌,细胞治疗硬仗才开始
phirda • Jun 19, 2026
Eight in vivo CAR T biotechs to follow closely
labiotech • Jun 17, 2026
Capstan Therapeutics Management
Leadership team at Capstan Therapeutics
Director
Athena Countouriotis
Chief Technology Officer
Priya Karamali

Join now and verify your accreditation status to gain access to:
- Capstan Therapeutics Current Valuation
- Capstan Therapeutics Stock Price
- Capstan Therapeutics Management
- Available deals in Capstan Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Capstan Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Capstan Therapeutics Revenue and Financials
- Capstan Therapeutics Highlights
- Capstan Therapeutics Business Model
- Capstan Therapeutics Risk Factors
- Capstan Therapeutics Research Report from SACRA Research
Trading Capstan Therapeutics Stock
How to invest in Capstan Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Capstan Therapeutics through EquityZen funds. These investments are made available by existing Capstan Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Capstan Therapeutics stock?
Shareholders can sell their Capstan Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 470K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 54K private placements completed across 500+ companies, EquityZen leads the way in delivering "Private Markets for the Public."





